Vimarsana
Biggest News Aggregation in the World

Dave Helsel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Helsel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Helsel Today - Breaking & Trending Today

AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 18.2% in April - Vimarsana News

AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 18.2% in April

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Based on an average daily trading volume, of 336,700 shares, the […]

AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 18.2% in April - Vimarsana News

AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Down 18.2% in April

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Currently, 2.0% of the shares of the company are sold short. Based on an […]

AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Drop in Short Interest - Vimarsana News

AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Drop in Short Interest

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a decrease of 18.2% from the March 31st total of 923,300 shares. Approximately 2.0% of the company’s stock are short sold. Based on […]

AngioDynamics (NASDAQ:ANGO) Downgraded by Raymond James to "Outperform" - Vimarsana News

AngioDynamics (NASDAQ:ANGO) Downgraded by Raymond James to "Outperform"

Raymond James downgraded shares of AngioDynamics (NASDAQ:ANGO – Get Rating) from a strong-buy rating to an outperform rating in a report released on Monday morning, Marketbeat.com reports. The brokerage currently has $13.00 price target on the medical instruments supplier’s stock, down from their previous price target of $14.00. Separately, StockNews.com assumed coverage on shares of […]

FY2023 Earnings Estimate for AngioDynamics, Inc. Issued By Zacks Research (NASDAQ:ANGO) - Vimarsana News

FY2023 Earnings Estimate for AngioDynamics, Inc. Issued By Zacks Research (NASDAQ:ANGO)

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) – Equities research analysts at Zacks Research lowered their FY2023 EPS estimates for AngioDynamics in a research report issued to clients and investors on Wednesday, April 12th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.06) per share for the year, down from […]